Skip to content

Clinical application of nasal high flow oxygen delivery (HFNC) in painless bronchoscopy

To observe whether transnasal high flow oxygen inhalation (HFNC) can improve the oxygenation of patients during painless bronchoscopy under general anesthesia compared with traditional transnasopharyngeal ventilation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059069
Enrollment
Unknown
Registered
2022-04-23
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing bronchoscopy

Interventions

HFNC group:Transnasal high flow oxygen delivery (HFNC) for painless bronchoscopy
Oxygen inhalation through nasal catheterization:Oxygen inhalation through nasal catheter is used for painless bronchoscopy

Sponsors

Taizhou Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients requiring painless bronchoscopy or bronchoscopy ultrasound examination (EBUS); 2. Age: 18-75, no gender limitation; 3. Patients willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Blood oxygen saturation below 90% after entry; 2. Preoperative visit to patients with difficult airway; 3. Patients with nasopharyngeal obstruction, skull base fracture, and presence of nasopharyngeal ventilation or HFNC contraindications; 4. Severe cardiorespiratory and renal dysfunction, severe psychoneurotic or psychological disorders; 5. Pregnant and lactating patients; 6. BMI>30kg/m2 or <18 kg/m2.

Design outcomes

Primary

MeasureTime frame
The incidence of hypoxemia;Incidence of oxygen failure;Minimum oxygen saturation;

Secondary

MeasureTime frame
Hemodynamic changes;Sedation score;Adverse reactions;

Countries

China

Contacts

Public ContactNanjin Chen

Taizhou Hospital of Zhejiang Province

chennj@enzemed.com+86 13750668783

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026